SPY330.30+3.33 1.02%
DIA272.81+1.37 0.50%
IXIC10,963.64+184.84 1.71%

Myovant Sciences shares are trading higher after the company announced that the FDA accepted its new drug application for a once-daily Relugolix combination tablet for the Uterine Fibroids.

Benzinga · 08/17/2020 17:48